Ostatní
Návod 
KalVista Pharmaceuticals, Inc.
KALV
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.5B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-5
PS
11
Cena 1R
8-19
⌀ Cena
13.25
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
24-03-2026
Poslední dividenda
Profil
KalVista Pharmaceuticals, Inc., klinická farmaceutická společnost, objevuje, vyvíjí a komercializuje malé molekulární proteázové inhibitory pro nemoci s neuspokojenými potřebami. Portfolio produktů společnosti zahrnuje malé molekulární inhibitory kallikreinu v plazmě zaměřené na dědičný angioedém (HAE) a diabetický makulární edém (DME) a perorální inhibitory kallikreinu v plazmě. Mezi jeho produkty patří KVD001, inhibitor kallikreinu v plazmě, který dokončil klinickou studii fáze II pro léčbu DME; sebetralstat, který zahajuje studii fáze 3 KONFIDENT jako potenciální perorální, na vyžádání aplikovanou léčbu atak dědičného angioedému; KVD824, perorální přípravek kandidující na léčbu dědičného angioedému; a Factor XIIa, program perorálního inhibitoru, který je v preklinickém stádiu zaměřen na enzym v dědičném angioedému. Společnost sídlí v Cambridge ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
150
Založení
2015-04-09
Podobné společnosti
$ 2.53
+ $ 0.17
$ 9.92
- $ 0.58
$ 10.80
+ $ 0.24
$ 6.48
+ $ 0.04
$ 6.61
+ $ 0.02
$ 8.17
+ $ 0.10
$ 34.23
- $ 0.96
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 75.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.7 | 12.7 | 16.1 | 8.4 | 1.5 | 2.1 | 1.8 | 0.4 | 1.5 | |
| Cost of Revenues | 23.5 | 0.0 | 86.2 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 51.6 | 0.0 | -86.2 | -0.8 | 0.0 | 12.7 | 12.7 | 16.1 | 8.4 | 1.5 | 2.1 | 1.8 | 0.4 | 1.5 |
| Revenue | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 59.9 | 13.7 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 5.8 | 1.2 | 0.6 | 15.9 | 0.0 | 0.0 | 0.0 | 25.2 | 0.2 | 19.1 | |
| Gross Profit | 54.1 | 12.5 | 0.8 | -15.9 | 0.0 | 0.0 | 0.0 | -25.2 | -0.2 | -19.1 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 80.3 | 70.2 | 41.3 | 40.2 | 35.0 | 18.2 | 12.7 | 14.7 | 8.3 | 4.2 | 2.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 30.6 | 26.4 | 16.6 | 13.0 | 10.9 | 8.9 | 11.2 | 2.7 | 1.6 | 1.4 | 1.4 | |
| Depreciation & Amortization | 1.5 | 0.9 | 0.8 | 0.8 | 2.1 | -0.3 | 0.9 | 0.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Operating Expenses | 225.0 | 188.0 | 54.3 | 110.9 | 96.6 | 57.9 | 53.2 | 45.9 | 27.1 | 23.8 | 17.3 | 9.9 | 5.6 | 3.4 | |
| Operating Income | -173.4 | -188.0 | -140.4 | -110.9 | -96.6 | -57.9 | -40.5 | -29.8 | -18.7 | -22.3 | -15.2 | -8.1 | -5.2 | -1.8 |
| Operating Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 0.6 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | ||
| Total Operating Expenses | 67.5 | 58.5 | 59.8 | 39.1 | 42.9 | 45.8 | 44.2 | 23.2 | 32.9 | 10.7 | ||
| Operating Income | -13.3 | -46.1 | -59.0 | -55.0 | -42.9 | -45.8 | -44.2 | -48.5 | -33.2 | -29.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.1 | 6.4 | 0.0 | 2.2 | 1.1 | 0.9 | 1.8 | 1.4 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 19.9 | 5.8 | 0.0 | 0.0 | 1.1 | 0.0 | 0.0 | -9.2 | -2.9 | -3.7 | -3.7 | -0.9 | 0.4 | 0.3 | |
| Other Expense | 2.6 | 7.9 | 5.3 | 18.0 | 14.3 | 11.7 | 11.3 | 7.7 | 2.8 | 3.7 | 3.7 | 0.8 | -0.1 | 0.0 | |
| IBT | -170.8 | -180.1 | -135.1 | -92.9 | -82.3 | -46.2 | -29.2 | -20.7 | -15.8 | -18.6 | -11.4 | -7.2 | -5.7 | -2.1 | |
| Income Tax Expense | -3.6 | 3.4 | -8.5 | -18.1 | -13.8 | -1.8 | -0.1 | 0.1 | -1.3 | -5.1 | -5.4 | -0.9 | 0.5 | 0.2 | |
| Net Income | -167.2 | -183.4 | -126.6 | -74.9 | -68.5 | -44.5 | -29.1 | -20.8 | -15.8 | -18.6 | -11.4 | -7.2 | -5.7 | -2.1 |
| Net Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.4 | 1.9 | 1.8 | 2.0 | 1.4 | 1.4 | 1.7 | 1.5 | 0.7 | 0.8 | ||
| Interest Expense | 8.6 | 4.8 | 3.5 | 2.9 | 2.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | 0.8 | -1.3 | 1.1 | 1.9 | -1.3 | 3.5 | 3.8 | 3.8 | 4.1 | 2.1 | ||
| IBT | -12.5 | -47.3 | -57.9 | -53.1 | -44.3 | -42.3 | -40.4 | -44.6 | -29.0 | -27.7 | ||
| Income Tax Expense | -7.1 | 2.2 | 2.2 | -0.9 | 4.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Net Income | -5.4 | -49.5 | -60.1 | -52.2 | -48.5 | -42.3 | -40.4 | -44.6 | -29.0 | -27.7 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.68 | $-2.80 | $-2.33 | $-1.64 | $-1.38 | $-1.53 | $-4.00 | $-19.34 | $-27.44 | $-7.83 | $-2.83 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.68 | $-2.80 | $-2.33 | $-1.64 | $-1.38 | $-1.53 | $-4.00 | $-19.34 | $-27.44 | $-7.83 | $-2.83 | |
| Shares Outstanding | 50.5 | 49.7 | 36.8 | 27.9 | 24.5 | 19.1 | 17.7 | 15.1 | 10.3 | 4.6 | 0.6 | 0.3 | 0.7 | 0.7 | |
| Diluted Shares Outstanding | 50.5 | 49.7 | 36.8 | 27.9 | 24.5 | 19.1 | 17.7 | 15.1 | 10.3 | 4.6 | 0.6 | 0.3 | 0.7 | 0.7 |
| Per Share Data | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 50.5 | 53.9 | 53.5 | 49.7 | 52.6 | 46.7 | 46.2 | 43.6 | 34.7 | 34.6 | ||
| Diluted Shares Outstanding | 50.5 | 53.9 | 53.5 | 49.7 | 52.6 | 46.7 | 46.2 | 43.6 | 34.7 | 34.6 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 31.8 | 98.6 | 31.8 | 56.2 | 30.7 | 50.6 | 15.8 | 32.0 | 51.1 | 31.0 | 21.8 | 3.9 | 9.8 | 8.2 | |
| Short Term Investments | 178.6 | 89.0 | 178.6 | 93.1 | 135.5 | 198.3 | 51.9 | 68.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 210.4 | 187.6 | 210.4 | 149.4 | 166.2 | 248.9 | 67.7 | 100.8 | 51.1 | 31.0 | 21.8 | 3.9 | 9.8 | 8.2 | |
| Accounts Receivable | 10.9 | 15.1 | 10.9 | 16.6 | 14.1 | 10.4 | 16.5 | 11.3 | 6.8 | 2.5 | 2.2 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 4.4 | 38.9 | 4.4 | 4.3 | 10.6 | 4.9 | 4.5 | 0.0 | 1.5 | 0.8 | 0.7 | 0.7 | 0.1 | 0.1 | |
| Total Current Assets | 225.7 | 241.7 | 225.7 | 172.3 | 193.6 | 264.3 | 88.7 | 115.5 | 59.4 | 34.2 | 24.7 | 4.6 | 9.9 | 8.3 |
| Current Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 243.5 | 124.3 | 98.6 | 167.3 | 41.6 | 31.8 | 31.8 | 23.1 | 57.7 | 49.4 | |
| Short Term Investments | 65.7 | 67.2 | 89.0 | 85.9 | 94.2 | 142.4 | 178.6 | 52.5 | 45.5 | 73.8 | |
| Total Cash & ST Investments | 309.2 | 191.5 | 187.6 | 253.2 | 135.8 | 174.3 | 210.4 | 75.6 | 103.2 | 123.3 | |
| Accounts Receivable | 7.1 | 6.5 | 15.1 | 9.4 | 0.0 | 12.3 | 10.9 | 23.7 | 0.0 | 0.0 | |
| Inventory | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 8.5 | 7.9 | 38.9 | 4.8 | 16.5 | 5.1 | 4.4 | 4.8 | 25.4 | 26.6 | |
| Total Current Assets | 325.2 | 205.9 | 241.7 | 267.4 | 152.3 | 191.6 | 225.7 | 104.1 | 128.6 | 149.8 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 9.1 | 2.0 | 9.1 | 10.8 | 10.0 | 7.5 | 3.7 | 2.4 | 1.8 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.6 | 7.1 | 0.6 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 1.9 | 0.1 | 0.1 | |
| Total Long-Term Assets | 9.7 | 9.1 | 9.7 | 10.9 | 10.2 | 7.7 | 3.8 | 2.6 | 2.0 | 0.1 | 0.1 | 2.1 | 0.2 | 0.2 | |
| Total Assets | 235.4 | 250.8 | 235.4 | 183.2 | 203.9 | 272.0 | 92.5 | 118.1 | 61.4 | 34.3 | 24.7 | 6.6 | 10.1 | 8.5 |
| Long-Term Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 12.3 | 7.2 | 2.0 | 7.2 | 7.9 | 8.0 | 9.1 | 9.5 | 9.8 | 10.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 2.4 | 2.4 | 7.1 | 1.4 | 0.7 | 0.6 | 0.6 | 0.4 | 0.3 | 0.1 | |
| Total Long-Term Assets | 14.7 | 9.6 | 9.1 | 8.6 | 8.6 | 8.6 | 9.7 | 9.9 | 10.1 | 10.5 | |
| Total Assets | 339.9 | 215.5 | 250.8 | 276.0 | 160.8 | 200.2 | 235.4 | 114.0 | 138.7 | 160.3 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.1 | 4.9 | 9.1 | 4.8 | 3.6 | 2.0 | 1.7 | 2.9 | 1.4 | 1.2 | 1.0 | 1.0 | 0.5 | 0.1 | |
| Short-Term Debt | 1.3 | 2.0 | 1.3 | 1.1 | 1.0 | 0.9 | 0.6 | 0.1 | 0.2 | 0.0 | 0.0 | 4.4 | 3.1 | 2.7 | |
| Other Current Liabilities | 12.4 | 27.3 | 12.4 | 9.1 | 7.0 | 6.9 | 5.5 | 5.6 | 3.1 | 1.9 | 2.2 | 1.6 | 0.4 | 0.2 | |
| Current Liabilities | 22.8 | 45.2 | 22.8 | 15.0 | 11.6 | 9.8 | 7.7 | 18.1 | 23.2 | 3.0 | 3.2 | 7.1 | 4.0 | 3.1 |
| Current Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.1 | 5.9 | 4.9 | 5.9 | 5.2 | 10.8 | 9.1 | 3.1 | 4.9 | 5.1 | |
| Short-Term Debt | 1.4 | 2.1 | 2.0 | 1.4 | 1.5 | 1.3 | 1.3 | 1.2 | 1.1 | 1.1 | |
| Other Current Liabilities | 24.1 | 19.0 | 27.3 | 18.3 | 15.4 | 10.4 | 12.4 | 14.8 | 11.7 | 8.0 | |
| Current Liabilities | 45.1 | 38.4 | 45.2 | 25.6 | 22.2 | 22.4 | 22.8 | 19.1 | 17.8 | 14.1 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 6.0 | 4.3 | 6.0 | 7.1 | 7.2 | 5.0 | 1.1 | 0.0 | 0.1 | 0.0 | 0.0 | 2.1 | 0.0 | 0.0 | |
| Capital Leases | 6.0 | 6.3 | 7.3 | 8.2 | 8.2 | 5.9 | 1.6 | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 0.0 | 0.0 | |
| Total Liabilities | 28.8 | 155.4 | 28.8 | 22.2 | 18.8 | 14.8 | 8.8 | 21.4 | 34.1 | 3.0 | 3.2 | 50.8 | 43.8 | 36.8 |
| Long-Term Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 148.2 | 4.0 | 4.3 | 4.3 | 4.7 | 5.0 | 6.0 | 6.3 | 6.5 | 6.9 | |
| Capital Leases | 10.6 | 6.1 | 6.3 | 5.8 | 6.2 | 6.3 | 6.0 | 7.4 | 7.7 | 8.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 322.9 | 174.7 | 155.4 | 130.9 | 26.8 | 27.4 | 28.8 | 25.4 | 24.3 | 21.0 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -469.7 | -653.2 | -469.7 | -343.1 | -250.2 | -167.8 | -121.6 | -92.5 | -71.7 | -55.9 | -37.3 | -47.8 | -34.4 | -28.7 | |
| Comprehensive Income | -3.5 | -5.2 | -3.5 | -3.1 | -3.9 | -1.4 | -1.9 | -1.9 | -1.1 | -2.6 | -0.1 | -0.5 | -0.4 | -0.4 | |
| Total Common Equity | 206.6 | 95.4 | 206.6 | 161.0 | 185.1 | 257.2 | 83.8 | 96.7 | 27.3 | 31.3 | 21.5 | -44.2 | -33.7 | -28.3 |
| Total Common Equity | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -739.1 | -713.3 | -653.2 | -600.9 | -552.4 | -510.2 | -469.7 | -425.1 | -396.0 | -368.4 | |
| Comprehensive Income | -6.7 | -6.4 | -5.2 | -2.2 | -2.7 | -2.9 | -3.5 | -3.3 | -3.5 | -2.9 | |
| Total Common Equity | 17.0 | 40.8 | 95.4 | 145.1 | 134.0 | 172.8 | 206.6 | 88.6 | 114.4 | 139.3 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 7.3 | 6.3 | 7.3 | 8.2 | 8.2 | 5.9 | 1.6 | 0.1 | 0.3 | 0.0 | 0.0 | 6.6 | 3.1 | 2.7 | |
| Book Value | 206.6 | 95.4 | 206.6 | 161.0 | 185.1 | 257.2 | 83.8 | 96.7 | 27.3 | 31.3 | 21.5 | -44.2 | -33.7 | -28.3 |
| Other | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 17.0 | 40.8 | 95.4 | 145.1 | 134.0 | 172.8 | 206.6 | 88.6 | 114.4 | 139.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -126.6 | -183.4 | -126.6 | -92.9 | -82.3 | -46.2 | -29.1 | -20.8 | -15.8 | -18.6 | -11.4 | -7.2 | -5.7 | -2.1 | |
| Depreciation & Amortization | 0.8 | 0.9 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 21.9 | 12.3 | 21.9 | 9.9 | 11.1 | 7.1 | 4.4 | 3.0 | 1.1 | 0.4 | 0.1 | 0.0 | 0.2 | 0.0 | |
| Change Working Capital | 15.2 | 15.0 | 15.2 | 7.4 | -12.3 | 8.3 | -20.6 | -18.8 | 25.8 | -4.2 | -0.2 | 0.8 | 0.5 | 0.0 | |
| Change In Accounts Receivable | 8.2 | -3.6 | 8.2 | -2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 4.3 | -5.0 | 4.3 | 1.1 | 1.7 | 0.2 | -1.0 | 1.5 | 0.2 | -1.6 | 0.4 | 0.2 | 0.3 | 0.0 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -1.1 | 2.3 | -0.5 | 0.1 | 4.9 | 0.1 | 0.0 | -0.1 | -0.7 | -1.4 | -1.7 | 0.0 | 0.0 | 0.1 | |
| Cash from Operations | -89.2 | 0.0 | 0.0 | -75.3 | -78.1 | -30.2 | -44.8 | -36.4 | 10.6 | -23.7 | -13.2 | -6.4 | -4.9 | -1.8 |
| Cash Flow From Operating Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -5.4 | -49.5 | -60.1 | -52.2 | -48.5 | -42.3 | -40.4 | -44.6 | -29.0 | -27.7 | |
| Depreciation & Amortization | 0.6 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Stock-Based Compensation | 0.0 | 6.2 | 5.4 | -8.6 | 2.6 | 0.0 | 3.0 | 12.7 | 0.0 | 0.0 | |
| Change Working Capital | -13.5 | -18.8 | -4.7 | 18.8 | 5.6 | 0.2 | -2.3 | 16.6 | -1.0 | 3.8 | |
| Change In Accounts Receivable | -12.2 | -6.6 | -1.1 | 2.8 | 3.2 | -1.1 | -1.3 | 14.4 | -2.1 | -2.0 | |
| Change In Accounts Payable | -1.9 | 5.0 | 2.5 | -1.4 | 0.8 | -5.9 | 1.5 | 6.1 | -1.9 | 0.1 | |
| Change In Inventories | -3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 63.6 | 29.2 | 4.7 | 1.5 | 7.4 | 2.2 | -0.7 | 0.0 | 2.3 | 3.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.6 | -0.9 | 0.0 | -1.2 | -0.9 | -0.1 | -0.2 | -1.1 | -1.4 | -0.1 | 0.0 | -0.1 | 0.0 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | -57.9 | -57.9 | 147.7 | -16.8 | 69.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -189.2 | -30.6 | -189.2 | -98.2 | -136.9 | -201.2 | -49.8 | -79.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 105.0 | 122.5 | 105.0 | 140.9 | 195.7 | 53.6 | 66.8 | 11.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.3 | 0.0 | 0.0 | 57.9 | 57.9 | -147.7 | 16.8 | -69.4 | 0.0 | 34.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -84.7 | 0.0 | 0.0 | 41.4 | 57.9 | -147.7 | 16.8 | -69.4 | -1.4 | 34.1 | 0.0 | -0.1 | 0.0 | -0.1 |
| Cash Flow From Investing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.4 | 0.0 | -0.3 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 21.0 | 0.0 | -20.0 | 38.1 | -6.6 | 0.0 | -1.0 | -141.5 | -18.2 | -3.8 | |
| Sales of Investment | -22.5 | 0.0 | 41.7 | 21.2 | 15.2 | 48.9 | 38.2 | 15.5 | 11.6 | 32.5 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.2 | -0.2 | 0.0 | 0.0 | 0.0 | -0.2 | -0.4 | |
| Debt Issued | -0.9 | -1.0 | -0.9 | 0.0 | 2.3 | 4.3 | 1.6 | 0.0 | 0.4 | 0.0 | -6.6 | 3.5 | 0.5 | 3.1 | |
| Issuance of Common Stock | 150.7 | 0.0 | 0.0 | 56.6 | 0.0 | 210.6 | 11.4 | 87.9 | 9.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 150.7 | 0.0 | 0.0 | 1.5 | 1.6 | 1.5 | 0.2 | 0.2 | 0.0 | 0.0 | 33.0 | 8.7 | 6.6 | 6.0 | |
| Cash from Financing | 150.7 | 0.0 | 0.0 | 58.1 | 1.6 | 212.1 | 11.6 | 87.9 | 9.0 | 0.0 | 33.0 | 8.7 | 6.4 | 5.6 |
| Cash Flow From Financing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 149.6 | 143.4 | -0.2 | 0.5 | -0.4 | 0.0 | -1.1 | -0.1 | -0.3 | -0.3 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -24.4 | 99.8 | -24.4 | 25.5 | -19.9 | 34.8 | -16.2 | -19.0 | 20.1 | 9.2 | 19.2 | 2.0 | 1.5 | 3.6 | |
| Closing Cash Balance | 31.8 | 131.6 | 31.8 | 56.2 | 30.7 | 50.6 | 15.8 | 32.0 | 51.1 | 31.0 | 21.8 | 2.5 | 9.8 | 8.2 |
| Cash position | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -243.5 | 126.4 | -7.3 | -35.7 | 126.4 | 9.7 | 0.1 | 8.7 | -34.6 | 8.3 | |
| Closing Cash Balance | 0.0 | 167.9 | 124.3 | 132.3 | 167.9 | 41.6 | 31.8 | 31.8 | 23.1 | 57.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -89.9 | -153.3 | -89.7 | -76.5 | -79.1 | -30.3 | -45.0 | -37.4 | 9.1 | -23.8 | -13.2 | -6.5 | -4.9 | -1.9 | |
| Real Free Cash Flow | -111.8 | -165.6 | -111.6 | -86.4 | -90.2 | -37.4 | -49.5 | -40.4 | 8.1 | -24.2 | -13.3 | -6.5 | -5.1 | -2.0 |
| Free Cash Flow | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 45.5 | -32.7 | -54.8 | -40.0 | -32.8 | -39.8 | -40.2 | -15.2 | -27.6 | -19.8 | |
| Real Free Cash Flow | 45.5 | -38.9 | -60.2 | -31.4 | -35.4 | -39.8 | -43.3 | -28.0 | -27.6 | -19.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -5.1 | -7.2 | -1.4 |
| P/S | 11.4 | 107.7 | 9.4 |
| P/B | 50.5 | 5 | 5.2 |
| P/FCF | -10.1 | -0.6 | -1.5 |
| Market cap | $0.5 | $2.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 9.8 % | 0 % |
| Debt to Income | -89.5 % | -15.8 % | 0 % |
| Debt to Free cash flow | -176.2 % | -3185.2 % | 0 % |
| Interest expense percentage | -11.5 % | 3.2 % | 44.7 % |
| Current ratio | 7.2 | 10 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -983.4 % | -79.9 % | 0 % |
| ROA | -49.2 % | -49.4 % | 0 % |
| CapEx to Revenue | -0.1 % | 511.3 % | 0 % |
| RaD to Revenue | 0 % | 8303.4 % | 0 % |
| ROEM | 277,937.0 | 75851.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 68.7 % | 74.9 % | 68.7 % |
| Operating margin | -231.1 % | -12631.7 % | 35.5 % |
| Net margin | -222.8 % | -13691 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 50.5 mil | 19.9 mil |
| Employee count | 0.3 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
